Results 101 to 110 of about 22,681 (186)
Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications
Therapeutic Advances in Medical Oncology, 2017 Soft tissue sarcomas are a rare and multifaceted group of solid tumours. Neoadjuvant chemotherapy is increasingly used to limit loss of function after wide surgical excision with the ultimate aim of improving patient survival.
Sandro Pasquali, Alessandro Gronchi
doaj +1 more source
Genomics, 1994 We report here the physical mapping of recurrent chromosome 12q13-q15 breakpoints in cell lines derived from primary myxoid liposarcoma, lipoma, uterine leiomyoma, and pleomorphic adenoma of the salivary glands. In fluorescence in situ hybridization (FISH) experiments, we first mapped the position of the chromosome 12 translocation breakpoint in ...
E F, Schoenmakers +9 more
openaire +2 more sources
Myxoid liposarcoma in a 91-year-old patient [PDF]
, 2015 Background: Myxoid liposarcoma is a mesenchymal malignancy most commonly presenting in young adults. This tumor is known for its characteristic chromosomal rearrangement at the DDIT3 locus.
Sheffield, Brandon S., Nielsen, Torsten
core +1 more source
Primary Orbital Pleomorphic Liposarcoma: An Aggressive Course
, 2012 An aggressively poor course of primary orbital pleomorphic liposarcoma is presented. A 59-year-old man had suffered from multiple local recurrences and died 1 year after diagnosis of orbital pleomorphic liposarcoma.
Lee, Sang Yeul +5 more
core +1 more source
Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma
Drug Design, Development and Therapy, 2015 Rita De Sanctis,1 Andrea Marrari,1 Silvia Marchetti,1 Chiara Mussi,2 Luca Balzarini,3 Fabio Romano Lutman,3 Primo Daolio,4 Stefano Bastoni,4 Alexia Francesca Bertuzzi,1,5 Vittorio Quagliuolo,2 Armando Santoro1 1Department of Medical Oncology and ...
De Sanctis R +10 more
doaj
FUS–DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid Liposarcoma
, 2017 Purpose: Myxoid liposarcoma is an aggressive disease with particular propensity to develop hematogenic metastases. Over 90% of myxoid liposarcoma are characterized by a reciprocal t(12;16)(q13;p11) translocation.
Ilka Isfort +16 more
core +1 more source
Molecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley +1 more source
Neoplasia: An International Journal for Oncology Research, 2017 Trabectedin has been approved for second-line treatment of soft tissue sarcomas. However, its efficacy to target sarcoma initiating cells has not been addressed yet.
Lucia Martinez-Cruzado +8 more
doaj +1 more source
Myxoid liposarcoma of the spermatic cord: A case report
, 2007 Introduction: Myxoid liposarcoma is a rare condition and a very little number of cases have been described in the spermatic cord to date. It presents as painless scrotal or inguinal masses that are often confused with hydroceles or inguinal hernias ...
Vuruşkan, Hakan +4 more
core
The FUS-DDIT3 interactome in myxoid liposarcoma
, 2019 Myxoid liposarcoma is a malignant fatty tumour that develops in the deep soft tissue. While local control rates are good, current chemotherapy options remain ineffective against metastatic disease.
Yu, Jamie Simin Emma
core +1 more source